Research Papers:

BRAF-activated lncRNA predicts gastrointestinal cancer patient prognosis: a meta-analysis

Yang-Hua Fan, Min-Hua Ye, Lei Wu, Miao-Jing Wu, Shi-Gang Lu and Xin-Gen Zhu _

PDF  |  HTML  |  How to cite

Oncotarget. 2017; 8:6295-6303. https://doi.org/10.18632/oncotarget.14061

Metrics: PDF 2139 views  |   HTML 2831 views  |   ?  


Yang-Hua Fan1,*, Min-Hua Ye1,*, Lei Wu1, Miao-Jing Wu1, Shi-Gang Lu1, Xin-Gen Zhu1

1Department of Neurosurgery, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi Province, People’s Republic of China

*These authors contributed equally to this work

Correspondence to:

Xin-Gen Zhu, email: [email protected]

Shi-Gang Lu, email: [email protected]

Keywords: BANCR, long non-coding RNA, gastrointestinal cancer, biomarker, meta-analysis

Received: October 20, 2016     Accepted: December 13, 2016     Published: December 21, 2016


BRAF activated non-coding RNA (BANCR) is often dysregulated in cancer. We performed a meta-analysis to clarify its functions as a prognostic indicator in malignant tumors. We searched the PubMed, Medline, OVID, Cochrane Library, and Web of Science databases to identify BANCR-related studies. Nine original studies and 898 total patients were included in the meta-analysis. Hazard ratios (HR) and 95% confidence intervals (CI) were extracted from the included studies to determine the relationship between BANCR expression and patient overall survival (OS). Odds ratios (OR) were calculated using RevMan 5.3 software to assess associations between BANCR expression and pathological parameters. High BANCR expression correlated with lymph node metastasis (LNM) (OR = 3.41, 95% CI: 1.82–6.37, P = 0.0001), distant metastasis (DM) (OR = 2.98, 95% CI: 1.76–5.07, P < 0.0001), tumor stage (OR = 3.11, 95% CI: 1.89–5.12, Z = 3.25, P < 0.0001), and poor OS (pooled HR = 1.98, 95% CI: 1.20–3.27, P = 0.008) in gastrointestinal (GI) cancer patients, but not in non-GI cancer patients. Our results support the notion that BANCR as a promising prognostic biomarker in Chinese patients with GI cancer.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 14061